In our previous post on stem cells, we discussed how human-derived induced pluripotent stem cells (iPS) are being used to model “disease in a...

Carlsbad, CA is soon to be home to San Diego’s own community laboratory space. Much along the lines of Genspace in NYC and BioCurious in Sunnyvale...

Pharmaceutical innovation doesn’t just happen because a lot of money is thrown at it or the company has been restructured. It requires a setting...

Last week we talked about Stem cell research getting the “green light” and this week we continue with our stem cell blog series. Biology has long...

One welcome result of the pharmaceutical innovation crisis is a shift from blockbuster drugs to rare disease drugs. We are doing our own part to...

One of Scientist’s most popular blog posts of last year was an infographic depicting American attitudes towards stem cell research. Part of that...

Pharmaceutical innovation is a broad term that can encompass and affect any step of the drug discovery and development process, so how exactly are...

Scientific research in circadian rhythm has determined that our genes can quite accurately predict the time of our death due to natural causes...

With the fiscal cliff negotiations over for now, we turn our attention to the patent cliff. A lot of industry watchers and participants often...

Scientist’s Kevin Lustig recently blogged on mendelspod, explaining how the cost of drug development for pharmaceutical companies often leads to...